Market›Norbinaltorphimine
Company Profile

Norbinaltorphimine

Norbinaltorphimine is an opioid receptor antagonist used in scientific research. It is a highly selective inverse agonist for the κ-opioid receptor. In animals, nor-BNI blocks the effects of κ-opioids with a slow onset and an exceptionally long duration of action. It produces antidepressant-like and anxiolytic-like effects in animal models.

Legality
In the United States, a letter from Terrence L. Boos, Ph.D., Chief Drug & Chemical Evaluation Section Diversion Control Division at the DEA shows they consider nor-BNI a Schedule II substance as a derivative of noroxymorphone due to its broad definition in the CSA covering "derivatives". However, no court cases are known to exist for its prosecution and it is possible this could be challenged in court. == See also ==
Source: Wikipedia ↗
tickerdossier.comtickerdossier.substack.com